Tumor Reduction: This Therapeutics Company Presents Promising Data

Monopar Therapeutics Makes Groundbreaking Strides in Oncology Research: New Data Shows Tumor Reduction Benefit of Camsirubicin.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In an exciting development for the medical community and cancer patients worldwide, Monopar Therapeutics Inc. (Monopar) recently presented compelling data from its ongoing Phase 1b trial at the 2023 Connective…